Pappas Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 22
Average round size
info
The average size of a deal this fund participated in
$56M
Portfolio companies 17
Rounds per year 0.79
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.23
Exits 7
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Pharmaceutical
  • Health Care
  • Therapeutics
Summary

Pappas Capital is the famous VC, which was founded in 1994. The main department of described VC is located in the Durham. The company was established in North America in United States.

The typical case for the fund is to invest in rounds with 7-8 participants. Despite the Pappas Capital, startups are often financed by Fonds de solidaritu00e9 FTQ, Pappas Ventures, Go Capital. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Tekla Capital Management, RiverVest. In the next rounds fund is usually obtained by Venrock Healthcare Partners, Tekla Capital Management, RTW Investments LLC.

Among the most popular fund investment industries, there are Genetics, Health Care. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 3 of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight CuraSen Therapeutics, 4D Molecular Therapeutics, Amplyx Pharmaceuticals.

Comparing to the other companies, this Pappas Capital performs on 11 percentage points less the average number of lead investments. Speaking about the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2019. The top activity for fund was in 2018. The common things for fund are deals in the range of 50 - 100 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Pappas Capital:
Typical Co-investors
Pappas Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Pappas Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Asatsu DK Hokkaido Prefecture, Japan, Sapporo
Bank of Kochi Japan, Kochi, Kochi Prefecture
Beilun ZhongGang ZhuangShi China, Ningbo, Zhejiang
BonVenture Bayern, Germany, Munich
Changan Assets China, Shanghai
Charitable Leadership Foundation Clifton Park, New York, United States
Clearly Social Angels England, London, United Kingdom
Dera Game Japan, Tokyo
FourthGreen Capital Incline Village, Nevada, United States
Huaou Equity Investment China, Hangzhou, Zhejiang
KBL Healthcare Ventures New York, New York, United States
Lead Wealth Capital China, Shanghai
Orient Corporation Chiyoda, Japan
Shantou Dongfeng Venture Capital China, Guangdong, Shantou
Sylvain & CO -
Taleria Ventures -
TLC Capital Atlanta, Georgia, United States
Walvax Biotechnology China, Kunming, Yunnan
Werth Family Investment Associates -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Us2.ai

Artificial Intelligence
Health Care
Medical
Medical Device
mHealth
Software
$15M14 Apr 2022 Singapore, Central Region, Singapore

Plexium

Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
$102M23 Feb 2022 San Diego, California, United States

AvengeBio

Biotechnology
Health Care
Medical
$45M05 Jan 2022 Cambridge, Massachusetts, United States

BioAtla

Biotechnology
Health Care
Medical
$75M29 Sep 2021 San Diego, California, United States

Reneo Pharmaceuticals

Biotechnology
Medical
Pharmaceutical
$95M09 Dec 2020 San Diego, California, United States

Cyclerion Therapeutics

Biotechnology
Pharmaceutical
$24M31 Jul 2020 Cambridge, Massachusetts, United States

BioAtla

Biotechnology
Health Care
Medical
$72M15 Jul 2020 San Diego, California, United States

VelosBio

$137M08 Jul 2020 -

4D Molecular Therapeutics

Biotechnology
Drug Discovery
Genetics
$75M16 Jun 2020 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Pappas Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: